Greg Dyson

Professor

Wayne State University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (23)

Year:

2026

Year:

2026

Year:

2026

Sporadic pancreatic neuroendocrine tumors (pNETs) with wild type MEN1 represent a major yet largely ignored subset whose biology and metastatic potential remain poorly understood. Because metastasis can occur despite low histologic grade and modest mutational burden, we hypothesized that metastatic competence in MEN1-wild-type pNETs reflects quantitative reinforcement of shared oncogenic pathways rather than distinct mutational processes. We profiled 75 primary low-grade pNETs by whole-exome and RNA sequencing, including 25 percent with lymph node and/or liver metastasis, and integrated genomic and transcriptomic data to connect pathway lesions with expression state. Metastatic tumors showed a slight increase in mutation frequency but conserved base-substitution spectra relative to non-metastatic cases, and adverse clinicopathologic features were enriched in Grade 2 disease. Aggregating alterations to pathways revealed broad convergence on canonical networks, with transcriptomic analyses demonstrating cohort-wide enrichment of Calcium, WNT, and KRAS/PI3K-AKT programs in metastasis. Intersection of significantly mutated genes with differentially expressed genes identified a focused 29-gene overlap, including RYR1 and ZNF273, that marks these convergent axes and distinguishes metastatic from non-metastatic tumors. Gene set enrichment confirmed preferential activation of Calcium, WNT, and PI3K-AKT signaling in metastatic tumors, consistent with a network-intensity model of progression. Finally, upstream-regulator analysis (iPathwayGuide) and gene-centric perturbation mapping (Gene2Drug) nominated candidate targeted and repurposable agents predicted to reverse the metastatic expression phenotype and flagged drugs unlikely to provide benefit, yielding a prioritized, testable therapeutic shortlist which includes fasudil and spaglumic acid. Convergent, domain-specific mutational patterns in highly mutated genes such as ZNF273 and CLCA1 define a molecular signature that could stratify metastatic risk in low-grade pNETs. Collectively, our data reframe metastasis in MEN1-wild-type low-grade pNETs as a property of pathway state rather than mutation quantity and provide a translational blueprint for biomarker-guided therapy development focused on Calcium, WNT, and KRAS/PI3K hubs.

Year:

2026

Neighborhood quality affects both socioeconomic factors and exposure to carcinogenic environmental pollutants, but the impacts of these factors on racial disparities in colorectal cancer mortality are not well described. We used the Centers for Disease Control and Prevention Environmental Justice Index social vulnerability module, environmental burden module (EBM), and the combined social–environmental score (SER) to assess relationships with colorectal cancer mortality by race and age in the Metropolitan Detroit Cancer Surveillance System. Among 13,505 patients with colorectal cancer [9,727 non-Hispanic White (NHW) and 3,778 non-Hispanic Black (NHB)], EBM quartile 4 versus 1 was more strongly associated with mortality among NHB early-onset (EO) cases than NHW EO cases [NHB: HR = 1.98, 95% confidence interval (CI), 1.20–3.26; NHW: HR = 1.40, 95% CI, 0.88–2.25]. SER quartile 4 versus 1 was more strongly associated with colorectal cancer mortality in EO (NHB: HR = 1.76, 95% CI, 0.93–3.31; NHW: HR = 1.53, 95% CI, 0.79–2.96) compared with later-onset cases (NHB: HR = 1.15, 95% CI, 0.87–1.52; NHW: HR = 1.39, 95% CI, 1.17–1.65) regardless of race. These associations in EO cases were strongest in colon tumors versus rectal tumors (EO EBM: colon HR = 2.08, 95% CI, 1.24–3.48 vs. rectum HR = 1.03, 95% CI, 0.64–1.66; EO SER: colon HR = 2.57, 95% CI, 1.38–4.79 vs. rectum HR = 0.84, 95% CI, 0.48–1.45). These results suggest the combination of socio-environmental burdens contributes to age and racial disparities in colorectal cancer mortality in metropolitan Detroit. Significance: Understanding the role of environmental justice in cancer survivorship could influence policy decisions, aiding intervention practices.

Year:

2025

Background: While NPM1-mutated AML in the absence of FLT3-ITD generally carries a favorable prognosis, large registry studies suggest the positive prognostic benefit may not extend to patients > 65 years of age. We examined this preferential, age-dependent prognostic impact through a real-world analysis of 2811 adult AML patients. Results: The median overall survival (OS) was significantly better in NPM1MT compared to NPM1WT patients [20.86 vs. 17 mo., p = 0.003]. When stratified by age, NPM1MT patients had higher OS than NPM1WT patients in the 55–65-year age group (28.62 vs. 16.3 mo., p ≤ 0.0001). This OS benefit was heterogenous and prevailed most strikingly in the 55–60 (68.3 vs. 15.6 mo., p = 0.002), and up to the 60–65-year group (mOS not estimable vs. 20 mo., p = 0.007), but not beyond 65 y. Notably, the ≤65 cohort was more enriched with dominant NPM1 (21% vs. 15%, p ≤ 0.001), while the >65 cohort was enriched with abnormal karyotype (20% in >65 years vs. 16% in ≤65 years, p = 0.001), and co-occurring SRSF2 and ASXL1 mutations (18.7% vs. 7.5%, p ≤ 0.0001 and 13.5% vs. 4.1%, p ≤ 0.0001 resp.). Conclusions: We demonstrate that in a real-world setting, the prognostic benefit of NPM1 does not extend beyond age 65, underscoring the need for age-adapted risk stratification models. This granular approach could prevent the potential overestimation of prognosis in older patients with NPM1MT AML and inform therapeutic decision making.

Year:

2025

Year:

2025

Year:

2025

Geographic distribution of EJI variables in metropolitan Detroit at the census tract level for ( A ) SVM raw scores categorized by quartile, ( B ) EBM raw scores categorized by quartile, and ( C ) combined SER raw scores categorized by quartile. For each variable, Q1 is depicted in light yellow, Q2 in light orange, Q3 in medium orange, and Q4 in dark orange. Raw score values corresponding to each quartile are shown in the legends. Census tracts without sufficient data to calculate scores are shown in black.

Year:

2025

Neighborhood quality affects both socioeconomic factors and exposure to carcinogenic environmental pollutants, but the impacts of these factors on racial disparities in colorectal cancer mortality are not well described. We used the Centers for Disease Control and Prevention Environmental Justice Index social vulnerability module, environmental burden module (EBM), and the combined social–environmental score (SER) to assess relationships with colorectal cancer mortality by race and age in the Metropolitan Detroit Cancer Surveillance System. Among 13,505 patients with colorectal cancer [9,727 non-Hispanic White (NHW) and 3,778 non-Hispanic Black (NHB)], EBM quartile 4 versus 1 was more strongly associated with mortality among NHB early-onset (EO) cases than NHW EO cases [NHB: HR = 1.98, 95% confidence interval (CI), 1.20–3.26; NHW: HR = 1.40, 95% CI, 0.88–2.25]. SER quartile 4 versus 1 was more strongly associated with colorectal cancer mortality in EO (NHB: HR = 1.76, 95% CI, 0.93–3.31; NHW: HR = 1.53, 95% CI, 0.79–2.96) compared with later-onset cases (NHB: HR = 1.15, 95% CI, 0.87–1.52; NHW: HR = 1.39, 95% CI, 1.17–1.65) regardless of race. These associations in EO cases were strongest in colon tumors versus rectal tumors (EO EBM: colon HR = 2.08, 95% CI, 1.24–3.48 vs. rectum HR = 1.03, 95% CI, 0.64–1.66; EO SER: colon HR = 2.57, 95% CI, 1.38–4.79 vs. rectum HR = 0.84, 95% CI, 0.48–1.45). These results suggest the combination of socio-environmental burdens contributes to age and racial disparities in colorectal cancer mortality in metropolitan Detroit. Significance: Understanding the role of environmental justice in cancer survivorship could influence policy decisions, aiding intervention practices.

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (24)

Natalie Snider

Wright State University

UNITED STATES
View details

Pei-Chung Lee

Wayne State University

UNITED STATES
View details

George Sledge

-

UNITED STATES
View details

Frank Cackowski

Assistant Professor

Karmanos Cancer Institute

UNITED STATES
View details

Samuel Kareff

University of Miami School of Medicine

UNITED STATES
View details

Hirva Mamdani

Karmanos Cancer Institute

UNITED STATES
View details

Jeffrey Taub

Wright State University

UNITED STATES
View details

Md. Hafiz Uddin

Assistant Professor (Research)

Karmanos Cancer Institute

UNITED STATES
View details

Mohammed Al Hallak

Assistant Professor

Wayne State University School of Medicine

UNITED STATES
View details

Elena Stoffel

Professor of Internal Medicine

University of Michigan

UNITED STATES
View details

Elisabeth I. Heath

Wayne State University School of Medicine

UNITED STATES
View details

Ira Winer

Professor

Wayne State University

UNITED STATES
View details

Ann G. Schwartz

Wayne State University School of Medicine

UNITED STATES
View details

Kristen S. Purrington

Associate Professor

Wayne State University School of Medicine

UNITED STATES
View details

Yubin Ge

Wayne State University School of Medicine

UNITED STATES
View details

Jay Yang

Professor

Wayne State University

UNITED STATES
View details

Luc Van Kaer

Vanderbilt University School of Medicine

UNITED STATES
View details

Heather Gibson

Associate Professor (tenured)

Wayne State University

UNITED STATES
View details

Hugo Jimenez

Assistant Professor

Wayne State University

UNITED STATES
View details

Theresa Hastert

Associate Professor

Wayne State University School of Medicine

UNITED STATES
View details

Suresh Balasubramanian

-

UNITED STATES
View details

Lisa Anne Polin

Research Professor

Wayne State University

UNITED STATES
View details

Gilberto Lopes

Associate Professor

Sylvester Comprehensive Cancer Center

UNITED STATES
View details

Carina Gronlund

University of Michigan

UNITED STATES
View details